Condensed Consolidated Statements Of Comprehensive Income (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Revenue:
Product	$ 11,721	$ 13,032
Collaborative and license	5,508	364
Total revenue	17,229	13,396
Operating (income) expenses:
Cost of product revenue	7,315	8,084
Research and development	3,161	2,632
Selling, general and administrative	5,928	4,500
Gain on sale of oilseed processing business	(31,481)	0
Restructuring charges	7	2,838
Total operating (income) expenses	(15,070)	18,054
Income (loss) from operations	32,299	(4,658)
Other income and expenses:
Other (expense) income, net	(341)	33
Interest expense	(668)	(1,094)
Gain on debt extinguishment upon repurchase of convertible notes	0	11,284
Loss on net change in fair value of derivative assets and liabilities	(324)	(1,813)
Total other (expense) income, net	(1,333)	8,410
Net income from continuing operations before income taxes	30,966	3,752
Income tax provision	(829)	0
Net income from continuing operations	30,137	3,752
Net (loss) income from discontinued operations	(15)	61
Net income attributed to Verenium Corporation	30,122	3,813
Net income per share, basic:
Continuing operations	$ 2.39	$ 0.30
Discontinued operations	$ 0.00	$ 0.00
Attributed to Verenium Corporation	$ 2.39	$ 0.30
Net income per share, diluted:
Continuing operations	$ 2.32	$ 0.30
Discontinued operations	$ 0.00	$ 0.00
Attributed to Verenium Corporation	$ 2.32	$ 0.30
Shares used in calculating net income per share, basic	12,608	12,604
Shares used in calculating net income per share, diluted	13,192	12,604
Comprehensive income	$ 30,122	$ 3,813